Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2015 | 08-2014 | 06-2014 | 08-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,723 | -62 | -5,579 | -57 | -57 |
| Depreciation Amortization | 240 | 5 | 133 | 5 | 5 |
| Income taxes - deferred | -24 | N/A | -814 | N/A | 0 |
| Accounts receivable | -157 | N/A | N/A | N/A | 0 |
| Accounts payable and accrued liabilities | -607 | N/A | 561 | N/A | 0 |
| Other Working Capital | -145 | -2 | 258 | 7 | 7 |
| Other Operating Activity | 1,782 | 20 | -62 | 8 | 8 |
| Operating Cash Flow | $-6,634 | $-39 | $-5,502 | $-38 | $-38 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -9 | N/A | 0 |
| Net Acquisitions | -1,000 | N/A | N/A | N/A | 0 |
| Purchase Of Investment | -5 | N/A | N/A | N/A | 0 |
| Investing Cash Flow | $-1,005 | $N/A | $-9 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 7,400 | 27 | 4,600 | 32 | 32 |
| Common Stock Issued | 5,000 | 18 | 637 | 8 | 8 |
| Other Financing Activity | -48 | -5 | 0 | 0 | 0 |
| Financing Cash Flow | $12,353 | $39 | $5,237 | $40 | $40 |
| Beginning Cash Position | 2,640 | 2 | 2,914 | 0 | 0 |
| End Cash Position | 7,353 | 2 | 2,640 | 2 | 2 |
| Net Cash Flow | $4,713 | $1 | $-274 | $2 | $2 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,634 | -39 | -5,502 | -38 | -38 |
| Capital Expenditure | N/A | N/A | -9 | N/A | 0 |
| Free Cash Flow | -6,634 | -39 | -5,511 | -38 | -38 |